Shifting Chemo Administration from Inpatient to Outpatient Setting Improves Care and Reduces Costs

Making Outpatient Chemo Possible
“Drug-Specific Videos for Patient Chemotherapy Education,” by James L. Weese, MD, FACS, et al.
“Chemo Companions Program: Medical and Graduate Students Take on New Roles in Patient Care,” by Sophia Tsesmelis Piccolino, LCSW, OSW-C, et al.
Podcast Episode 18: Reducing Cancer Drug Waste

Ali McBride, PharmD, MS, BCOP

Clinical Coordinator of Hematology/Oncology, The University of Arizona Cancer Center

Ali McBride, PharmD, MS, BCOP, is the Clinical Coordinator of Hematology/Oncology at The University of Arizona Cancer Center. Currently serving on the Board of the Association of Community Cancer Centers (ACCC), Dr. McBride also chairs the Awards Selection Committee as well as the Corporate Development Committee. In addition to being a long-time ACCC member, Dr. McBride has been actively involved with the American Society of Health-System Pharmacists (ASHP) and the Hematology/Oncology Pharmacy Association (HOPA).

Dr. McBride has been working on oncology drug shortages and has testified on behalf of HOPA at the U.S. Food and Drug Administration (FDA) Drug Shortage Workshop; presented on behalf of ACCC at the Washington, D.C., Congressional Session; and was an invited member of the ASHP Drug Shortage Stakeholders Meeting. Dr. McBride is also actively involved with biosimilar regulation and the pharmacoeconomic impact of biosimilars into the U.S. marketplace. He currently serves as a working group member for HOPA on its biosimilar committee. In addition, he serves on the National Quality Forum Cancer Standing Committee. He has published numerous articles on drug shortages, oral chemotherapy adherence, stem cell transplant, and biosimilar implementation into the U.S. healthcare market.

Dan Persky

Associate Professor of Medicine

Dr. Persky serves as an Associate Professor of Medicine at the University of Arizona College of Medicine. He is currently the Associate Director of the Clinical Investigations and Therapeutic Development Program. He specializes in Hematology/Oncology, particularly in lymphoid malignancies, such as lymphoma, CLL, and others.

Dr. Persky received his bachelor's degree from Harvard University and his medical degree from the Albert Einstein College of Medicine in New York. He completed his internship and residency at the Mayo Graduate School of Medicine in Rochester, Minnesota, then returned to New York to complete a three-year fellowship in Medical Oncology and Hematology at the Memorial Sloan-Kettering Cancer Center.

Dr. Persky is board certified by the American Board of Internal Medicine, sub-specialty of Medical Oncology.